Updated Jul 16, 2026
GAROFALO ELIZABETH A. has filed 3 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $42K.

| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | ALEC | Alector, Inc. | A — Grant or award | 28.7K | $0.00 | |
| 2026-06-04 | XENE | Xenon Pharmaceuticals Inc. | M — Option exercise | 2.6K | — | |
| 2026-06-01 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise | 8.1K | — | |
| 2025-09-02 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale | 1.6K | $25.98 | $42K |
| 2025-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise | 9.4K | — |
GAROFALO ELIZABETH A. is a corporate insider — currently tracked as Insider of Alector, Inc. (ALEC). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($42K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GAROFALO ELIZABETH A. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.